Proscias Concentriq Has Been Deployed By NASAs Jet Propulsion Laboratory To Transform Biomedical Research
Summary
Researchers will use the data to unlock new insights that combat the growing challenge of overdiagnosis, which results in unnecessary treatment of cancers that would have never caused medical problems for the patient. The MCL, which consists of independent, multi-disciplinary teams, was established to address this issue by undertaking comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to more accurately identify aggressive cancers and find minimally invasive methods of treatment. JPL is using Concentriq to host and manage the data repository, driving consistency for improved visibility and providing intuitive, secure access for the MCL’s team of researchers. The software can be rapidly deployed on existing IT infrastructure and works with leading scanners, laboratory information systems (LIS), and image analysis applications, offering seamless integrations with Philips, Leica, 3DHISTECH, Hamamatsu, and Visiopharm among other solutions. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics.